"Plasmids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS.
| Descriptor ID |
D010957
|
| MeSH Number(s) |
G05.360.600
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Plasmids".
Below are MeSH descriptors whose meaning is more specific than "Plasmids".
This graph shows the total number of publications written about "Plasmids" by people in this website by year, and whether "Plasmids" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 2 | 3 |
| 1998 | 0 | 2 | 2 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 3 | 4 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 1 | 2 |
| 2004 | 1 | 6 | 7 |
| 2005 | 0 | 6 | 6 |
| 2006 | 1 | 8 | 9 |
| 2007 | 0 | 3 | 3 |
| 2008 | 1 | 5 | 6 |
| 2009 | 1 | 1 | 2 |
| 2010 | 0 | 4 | 4 |
| 2011 | 0 | 5 | 5 |
| 2012 | 0 | 2 | 2 |
| 2013 | 0 | 2 | 2 |
| 2014 | 1 | 1 | 2 |
| 2015 | 1 | 1 | 2 |
| 2016 | 2 | 11 | 13 |
| 2017 | 29 | 67 | 96 |
| 2018 | 20 | 43 | 63 |
| 2019 | 2 | 18 | 20 |
| 2020 | 0 | 4 | 4 |
| 2021 | 0 | 5 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Plasmids" by people in Profiles.
-
Nucleic acid vaccines and CpG oligodeoxynucleotides for allergen immunotherapy. Curr Opin Allergy Clin Immunol. 2021 12 01; 21(6):569-575.
-
An easy method for developing fusion enabled SARS-CoV2 virus fusion mimic (SCFM), bypassing the need of Bio Safety Level (BSL) facility. Bioengineered. 2021 12; 12(1):4407-4419.
-
A novel DNA and protein combination COVID-19 vaccine formulation provides full protection against SARS-CoV-2 in rhesus macaques. Emerg Microbes Infect. 2021 Dec; 10(1):342-355.
-
Coronavirus Pseudotypes for All Circulating Human Coronaviruses for Quantification of Cross-Neutralizing Antibody Responses. Viruses. 2021 08 10; 13(8).
-
SARS-CoV-2 infection induces the activation of tissue factor-mediated coagulation via activation of acid sphingomyelinase. Blood. 2021 07 29; 138(4):344-349.
-
Producing molecular biology reagents without purification. PLoS One. 2021; 16(6):e0252507.
-
DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss. PLoS Negl Trop Dis. 2021 05; 15(5):e0009374.
-
Human Immunodeficiency Viruses Pseudotyped with SARS-CoV-2 Spike Proteins Infect a Broad Spectrum of Human Cell Lines through Multiple Entry Mechanisms. Viruses. 2021 05 21; 13(6).
-
SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways. J Med Virol. 2021 09; 93(9):5376-5389.
-
DNA vaccine candidate encoding SARS-CoV-2 spike proteins elicited potent humoral and Th1 cell-mediated immune responses in mice. PLoS One. 2021; 16(3):e0248007.